<code id='9DD19DF1F9'></code><style id='9DD19DF1F9'></style>
    • <acronym id='9DD19DF1F9'></acronym>
      <center id='9DD19DF1F9'><center id='9DD19DF1F9'><tfoot id='9DD19DF1F9'></tfoot></center><abbr id='9DD19DF1F9'><dir id='9DD19DF1F9'><tfoot id='9DD19DF1F9'></tfoot><noframes id='9DD19DF1F9'>

    • <optgroup id='9DD19DF1F9'><strike id='9DD19DF1F9'><sup id='9DD19DF1F9'></sup></strike><code id='9DD19DF1F9'></code></optgroup>
        1. <b id='9DD19DF1F9'><label id='9DD19DF1F9'><select id='9DD19DF1F9'><dt id='9DD19DF1F9'><span id='9DD19DF1F9'></span></dt></select></label></b><u id='9DD19DF1F9'></u>
          <i id='9DD19DF1F9'><strike id='9DD19DF1F9'><tt id='9DD19DF1F9'><pre id='9DD19DF1F9'></pre></tt></strike></i>

          00:00
          00:00 00:00 LIVE
          buffering
          Replay
          LIVE
          00:00 / 00:00
          LIVE
          CC
          Opacity :
          Share:
          Close

          leisure time

          author:leisure time    - browse:894
          IQVIA signage. -- health tech coverage from STAT
          Adobe

          The health data giant IQVIA became a dominant force by gobbling up its rivals. Over decades, it feasted on upstarts with new datasets or novel technologies, growing into a juggernaut with no peer in the business of brokering Americans’ medical information.

          Now, government regulators say, IQVIA’s appetite for acquisition is getting out of control — and must be reined in.

          advertisement

          A Federal Trade Commission lawsuit seeking to block its acquisition of the digital advertising firm DeepIntent marks a crossroads for the company and the multi-billion dollar medical advertising economy it serves. The agency, which is seeking an injunction and temporary restraining order in federal court, argues that IQVIA’s data vault has become so large — and revealing — that it forms the substrate of an entire industry focused on showering doctors and patients with marketing messages.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore